Methylglyoxal and glyoxalase I in atherosclerosis (Q38197343)

30 August 2017

1 reference

title

Methylglyoxal and glyoxalase I in atherosclerosis (English)

1 reference

Coenraad Dirk Adriaan Stehouwer

30 August 2017

1 reference

series ordinal

2

object named as

Coen D A Stehouwer

1 reference

30 August 2017

3

Casper G Schalkwijk

1 reference

30 August 2017

Nordin M J Hanssen

1

1 reference

30 August 2017

1 April 2014

1 reference

Biochemical Society Transactions

30 August 2017

1 reference

30 August 2017

42

1 reference

30 August 2017

2

1 reference

30 August 2017

443-449

1 reference

Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization

30 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Atherosclerotic plaque rupture: local or systemic process?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

N(omega)-(carboxymethyl)lysine depositions in human aortic heart valves: similarities with atherosclerotic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Methylglyoxal promotes oxidative stress and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Molecular basis of arterial stiffening: role of glycation - a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Advanced glycation end products: sparking the development of diabetic vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Glycation of LDL by methylglyoxal increases arterial atherogenicity: a possible contributor to increased risk of cardiovascular disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Effect of methylglyoxal on the physico-chemical and biological properties of low-density lipoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Glyoxalase I overexpression ameliorates renal ischemia-reperfusion injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Genomic sequence of human glyoxalase-I: analysis of promoter activity and its regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Posttranslational modification of human glyoxalase 1 indicates redox-dependent regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Nitric oxide inactivates glyoxalase I in cooperation with glutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Critical role of methylglyoxal and AGE in mycobacteria-induced macrophage apoptosis and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Hyperglycemia impairs proteasome function by methylglyoxal

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Pyridoxamine: the many virtues of a maillard reaction inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Alagebrium attenuates acute methylglyoxal-induced glucose intolerance in Sprague-Dawley rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Current therapeutic interventions in the glycation pathway: evidence from clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Anti-Hypertensive Agents Inhibit In Vivo the Formation of Advanced Glycation End Products and Improve Renal Damage in a Type 2 Diabetic Nephropathy Rat Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20140001

21 January 2018

Identifiers

DOI

10.1042/BST20140001

1 reference

30 August 2017

1 reference

PubMed ID

24646258